Dr. Elizabeth Roberts -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Elizabeth Roberts, a Rheumatology physician based in Rochester, NY. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Elizabeth Roberts has received $20,855.50 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Elizabeth Roberts
- Medical Specialty: Rheumatology
- Practice Location: Rochester, NY, New York
- NPI Number: 1769520938
- Transparency Score: 50/100
- Payment Records Span: 2025-03-15 to 2025-03-15
Payment Summary
Dr. Elizabeth Roberts has received a total of $20,855.50 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $20,855.50 per transaction.
- Total Payments Received: $20,855.50
- Number of Transactions: 1
- Average Payment: $20,855.50
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Rheumatology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
Payment Breakdown by Category
The following table shows how Dr. Elizabeth Roberts's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Research Funding | $20,855.50 | Clinical trial funding, research grants, and study-related payments |
The largest payment category for Dr. Elizabeth Roberts is Research Funding, accounting for 100% ($20,855.50) of total pharmaceutical payments received. This suggests active involvement in clinical trials and pharmaceutical research programs.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Elizabeth Roberts. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Eli Lilly and Company | $20,855.50 | 1 |
Dr. Elizabeth Roberts has a financial relationship with Eli Lilly and Company, receiving $20,855.50 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Elizabeth Roberts's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Elizabeth Roberts has received $20.9K across 1 pharmaceutical payments as a Rheumatology physician in Rochester, NY. Top paying companies include Eli Lilly and Company ($20.9K). Dr. Roberts received a single payment of $20,856 in 2025, which was designated for research. The entire payment originated from Eli Lilly and Company, indicating a 100% concentration from a single pharmaceutical manufacturer. This profile represents a single, substantial payment rather than a pattern of smaller, more frequent transactions.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Elizabeth Roberts is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
When consulting with Dr. Roberts, consider asking about the nature of the research funded by Eli Lilly and Company to understand its potential influence on treatment recommendations. Always feel free to ask your doctor directly about their pharmaceutical relationships.
Peer Comparison: How Dr. Elizabeth Roberts Compares to Other Rheumatology Physicians
For Rheumatology, Dr. Roberts' single, large research payment from Eli Lilly and Company is notable, especially given the specialty's common engagement with pharmaceutical companies for various purposes.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Elizabeth Roberts in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Eli Lilly and Company | $20,855.50 | research | N/A | 2025-03-15 | Not Assessed |
Frequently Asked Questions About Dr. Elizabeth Roberts's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
How much pharma money has Elizabeth Roberts received?
Elizabeth Roberts has received a total of $20.9K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.
Is Elizabeth Roberts taking too much pharma money?
Elizabeth Roberts has received $20.9K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Rheumatology), the types of payments, and how they compare to peers. The largest payment category is research ($20.9K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.
What pharma companies pay Elizabeth Roberts?
The top pharmaceutical companies paying Elizabeth Roberts are: Eli Lilly and Company ($20.9K). These payments cover various categories including consulting, meals, speaking fees, and research grants.
What kinds of payments does Elizabeth Roberts receive?
Elizabeth Roberts's payments by type: research: $20.9K. Research payments indicate involvement in clinical studies.
Should I switch doctors because of pharma payments?
Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.
How do Elizabeth Roberts's payments compare to other Rheumatology doctors?
To compare, look at the total amount ($20.9K), number of payments (1), and the types of payments received. Rheumatology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.
How can I verify Elizabeth Roberts's payment data?
You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1769520938). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.
Do pharma payments affect prescribing quality?
Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.
What stands out about Elizabeth Roberts's pharma payment profile?
The payment is exclusively for research, suggesting a potential focus on clinical trials or academic studies. Elizabeth Roberts has received $20.9K in total pharma payments.
How does Elizabeth Roberts compare to peers in Rheumatology?
For Rheumatology, Dr. Roberts' single, large research payment from Eli Lilly and Company is notable, especially given the specialty's common engagement with pharmaceutical companies for various purposes.
Are Elizabeth Roberts's pharma relationships typical for Rheumatology?
The high concentration from one company (Eli Lilly and Company) warrants attention, though the purpose (research) may explain this.
What should patients of Elizabeth Roberts know about these payments?
When consulting with Dr. Roberts, consider asking about the nature of the research funded by Eli Lilly and Company to understand its potential influence on treatment recommendations.
What patterns are visible in Elizabeth Roberts's payment history?
The data reflects only one transaction, making it difficult to establish long-term trends or broader engagement patterns.
Understanding This Doctor Payment Report
This transparency report for Dr. Elizabeth Roberts is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Rheumatology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Elizabeth Roberts's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Elizabeth Roberts and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- Rheumatology Specialty Payment Data -- See payment patterns for all rheumatology physicians
- New York Physician Payments -- Browse pharmaceutical payments to physicians in New York
- Rheumatology Physicians in New York -- Compare Dr. Elizabeth Roberts to peers in the same state and specialty
- Eli Lilly and Company Payment Profile -- View all payments made by Dr. Elizabeth Roberts's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Elizabeth Roberts's NPI (1769520938) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.